Molecular Diagnostics

International Union Against Sexually Transmitted Infections (IUSTI) World Congress 2024: key takeaways

International Union Against Sexually Transmitted Infections (IUSTI) World Congress 2024: key takeaways

The International Union Against Sexually Transmitted Infections (IUSTI) World Congress was recently held in Sydney, Australia. To better understand the landscape of sexually transmitted infections (STIs) and where diagnostic elements play a role, the Lab Insights team attended the conference to hear insights from global experts. Increasing access to STI care through diagnostics Increasing access […]

International Union Against Sexually Transmitted Infections (IUSTI) World Congress 2024: key takeaways Read More »

Increasing access to STI care through innovations in diagnostics

Increasing access to STI care through innovations in diagnostics

At the 25th International Union Against Sexually Transmitted Infections (IUSTI) World Congress, an interactive panel on increasing access to sexually transmitted infections through innovations in diagnostics was held. The interactive panel discussion with experts from around the world, brings diverse perspectives from academia, patient care, the laboratory, and public health sectors. The panellists shared their

Increasing access to STI care through innovations in diagnostics Read More »

How an emergency department in Taiwan uses molecular POC testing for respiratory infections

How an emergency department in Taiwan uses molecular POC testing for respiratory infections

Clinical laboratory teams around the world face the ongoing challenge of aligning their testing protocols with the goals of diagnostic stewardship. The idea is to ensure that every test provides actionable data to inform patient care and that unnecessary testing is kept to a minimum. Molecular testing—including both centralised laboratory assays and point-of-care (POC) tests—is

How an emergency department in Taiwan uses molecular POC testing for respiratory infections Read More »

Preventing transfusion-transmitted HEV infection in Thailand and beyond

Preventing transfusion-transmitted HEV infection in Thailand and beyond

As part of their ongoing efforts to ensure a safer blood supply for patients, blood banks around the world are increasingly implementing screening systems for hepatitis E virus (HEV), a common infection that can lead to potentially serious and life-threatening outcomes in some patients. In Thailand, the Thai Red Cross Society’s National Blood Center implemented

Preventing transfusion-transmitted HEV infection in Thailand and beyond Read More »

Optimising screening and triage for cervical cancer: Prof Mark Stoler on why biomarkers are best

Optimising screening and triage for cervical cancer: Prof Mark Stoler on why biomarkers are best

At the 35th International Papillomavirus Conference (IPVC) in April 2023, Prof Mark Stoler of the University of Virginia Health System spoke about detecting p16 and Ki-67, two biomarkers that indicate the presence of transforming HPV infections. His talk assesses their efficacy to definitively show the presence of HPV infection in a patient, showing how the

Optimising screening and triage for cervical cancer: Prof Mark Stoler on why biomarkers are best Read More »

Prof Mark Stoler on HPV primary screening with biomarker based triage

Prof Mark Stoler on HPV primary screening with biomarker based triage_thumbnail

While cervical cancer is preventable, an estimated 14,000 new cases are diagnosed in the United States every year, leading to almost 4,300 deaths from the disease. As Professor Emeritus of Pathology and Clinical Gynaecology at the University of Virginia Health System, Prof Mark Stoler is working towards preventing these deaths.  In this talk at the

Prof Mark Stoler on HPV primary screening with biomarker based triage Read More »

How labs can help to reduce the burden of STIs and infertility

How labs can help to reduce the burden of STIs and infertility

When it comes to women’s health, levels of knowledge and awareness of sexual and reproductive health vary in Asia Pacific. Diverse beliefs and cultures often lead to stigmatisation around Sexually Transmitted Infections (STIs). STIs like Chlamydia trachomatis (CT or Chlamydia) and Neisseria gonorrhoeae (GC or gonorrhoeae) can negatively impact the health of women causing a

How labs can help to reduce the burden of STIs and infertility Read More »

In a Taiwan clinical lab, molecular consolidation offers key benefits

In a Taiwan clinical lab, molecular consolidation offers key benefits

With more and more healthcare decisions guided by clinical diagnostic results, clinical lab teams are constantly looking for ways to deliver more results, faster, without breaking their budget. The recent trend of molecular consolidation — running many different molecular assays on a single system — offers a reliable path to expanding a lab’s test menu

In a Taiwan clinical lab, molecular consolidation offers key benefits Read More »

Total lab automation at Shifa International Hospital: Q&A with Dr Imran Nazir Ahmad

Total lab automation at Shifa International Hospital: Q&A with Dr Imran Nazir Ahmad

Widely respected as one of the top quaternary care facilities in Pakistan, Shifa International Hospital recently emerged as the first hospital in Asia Pacific and among the first in the world to pursue total automation of its clinical lab. In this Q&A with Dr Imran Nazir Ahmad, Chief of Pathology and Director of Laboratory at

Total lab automation at Shifa International Hospital: Q&A with Dr Imran Nazir Ahmad Read More »

Scroll to Top